Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139984
Status:
COMPLETED
Last Update Posted:
2017-02-02
First Post:
2005-08-29
Brief Title:
Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance
Sponsor:
University Hospital Basel Switzerland
Organization:
University Hospital Basel Switzerland
Study Overview
Official Title:
Impact of Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance in Medical Outpatients The Hyper-ABC Study
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether in patients with arterial hypertension treatment guidance using 24-hour blood pressure measurement results in better blood pressure control compared to treatment guidance using office blood pressure measurement
Detailed Description:
Blood pressure control in arterial hypertension remains poor despite the availability of effective drug treatment Therefore strategies to increase blood pressure control are urgently needed 24 hour blood pressure is a better predictor of cardiovascular morbidity and mortality than office blood pressure Furthermore the lower variability of measurements over time of 24 hour blood pressure could allow better adjustment of antihypertensive therapy However there are only scarce data about antihypertensive treatment adjustment using 24 hour blood pressure instead of office blood pressure
Aim To test the hypothesis that a 24 hour blood pressure guided therapy is is more effective in reaching blood pressure control when compared to conventional office blood pressure guided therapy
Aim To test the hypothesis that a 24 hour blood pressure guided therapy is is more effective in reaching blood pressure control when compared to conventional office blood pressure guided therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None